Quick Read
DKA and HHS are related hyperglycaemic emergencies, but they are not the same metabolic state. DKA is defined by hyperglycaemia or diabetes together with ketosis and metabolic acidosis. HHS is dominated by severe hyperglycaemia and hyperosmolality with little or no significant ketoacidosis. Mixed states also occur.
The distinct Medicine Web job is: hyperglycaemic crisis suspicion → DKA/HHS/mixed classification → dehydration/perfusion/electrolyte/osmolality assessment → fluid and insulin strategy → potassium and other electrolyte management → repeated ketone/glucose/osmolality/acid-base receipt → identify precipitant → resolution criteria → transition to chronic diabetes care → recurrence prevention.
Wait, What? Very High Glucose Does Not Tell You Whether the Patient Has DKA or HHS
The 2024 international consensus report revised diagnostic criteria for hyperglycaemic crises and explicitly recognises DKA, HHS and mixed DKA/HHS presentations. Glucose concentration alone does not define the whole emergency.
Core anti-collapse rules: high glucose ≠ DKA automatically; ketones ≠ DKA without the required acid-base context; HHS ≠ DKA without ketones; falling glucose ≠ crisis resolved; insulin started ≠ potassium risk solved; discharge ≠ precipitant understood.
The Hyperglycaemic Crisis Tube
Symptoms/high glucose → bedside and laboratory confirmation → DKA/HHS/mixed state → perfusion/dehydration/electrolyte/osmolality state → fluids → insulin where appropriate → potassium and electrolyte correction → repeated metabolic receipt → precipitant search → resolution criteria → transition from IV to subcutaneous insulin where relevant → diabetes education and follow-up → recurrence prevention.
1. The Owner Is the Acute Metabolic Failure State
The Endocrine & Metabolic Medicine Web owns diabetes and glucose regulation broadly. This node owns the acute life-threatening transition where insulin deficiency or severe metabolic decompensation creates ketosis, acidosis, hyperosmolality, major dehydration or combinations.
2. DKA Is a Ketone-and-Acidosis Problem
In DKA, inadequate effective insulin allows accelerated lipolysis and ketone production, producing metabolic acidosis. Hyperglycaemia contributes osmotic diuresis and fluid loss, but glucose is only one part of the syndrome.
For eduKateAI, DKA should preserve glucose + ketone state + bicarbonate/pH + potassium + renal function + volume/perfusion state.
3. HHS Is Dominated by Hyperosmolality and Dehydration
HHS usually develops with enough insulin activity to limit major ketogenesis but not enough to prevent severe hyperglycaemia. Osmotic diuresis can produce profound dehydration and elevated serum osmolality, with neurological consequences in severe cases.
Anti-collapse rule: HHS ≠ simply “more severe DKA”.
4. Mixed DKA/HHS Is a Real State
Some patients meet features of both disorders. The 2024 consensus specifically recognises overlap, which matters because treatment needs to respect both ketoacidosis and hyperosmolar physiology.
5. Fluids Correct Circulation and Osmotic Loss
Hyperglycaemia causes urinary water and electrolyte loss. Fluid therapy supports circulation and helps reverse hyperosmolality, but the rate and composition of replacement depend on cardiovascular, renal, sodium and osmolar states.
RFE rule: fluid is a physiological intervention, not a fixed ritual.
6. Potassium Can Fall Even When It Starts Normal or High
Total-body potassium is often depleted despite a normal or elevated initial serum concentration. Insulin therapy and correction of acidosis can shift potassium back into cells and reveal or worsen hypokalaemia.
Core distinction: serum potassium at presentation ≠ total-body potassium reserve.
7. Insulin Stops Ketogenesis and Corrects Hyperglycaemia
Insulin is central to DKA treatment and used in HHS according to the metabolic state. The safe route depends on potassium, fluid resuscitation, glucose trajectory and severity.
The Pharmacy Web owns medicine identity and dosing frameworks; this node owns the metabolic reason insulin is being used and what constitutes resolution.
8. Glucose Can Normalise Before Ketoacidosis Resolves
As insulin and fluids work, glucose can fall faster than ketones and acidosis resolve. Dextrose may therefore be added while insulin continues in DKA so ketone clearance can finish safely.
Anti-collapse rule: normal glucose ≠ DKA resolved.
9. Osmolality Must Change Safely
In HHS, rapid shifts in effective osmolality can be dangerous. Treatment therefore tracks glucose, sodium and osmolality together rather than chasing one laboratory value.
10. The Precipitant Is Often the Real Prevention Target
Infection, missed insulin, new diabetes, myocardial infarction, stroke, medication effects and other acute illnesses can precipitate hyperglycaemic crises. Treating the metabolic emergency without identifying the trigger leaves recurrence risk unresolved.
11. Infection Is a Common Cross-Owner
When infection precipitates DKA or HHS, the Infectious Disease & One Health Web owns the infection, while the Sepsis Web owns infection-related organ dysfunction if present.
12. Kidney Function Changes the Metabolic Picture
Renal dysfunction alters potassium handling, fluid tolerance and clearance of glucose and ketones. The Acute Kidney Injury & Renal Recovery Web owns the kidney trajectory when acute renal dysfunction is present.
13. Resolution Needs Explicit Criteria
The 2024 consensus moved toward direct metabolic resolution criteria rather than relying on anion gap alone in all cases. The point for the knowledge architecture is that treatment should end because the crisis physiology has resolved, not because a clock has elapsed.
14. Transition to Chronic Insulin Is a Handoff State
When IV insulin is no longer needed, overlap and transition to a subcutaneous regimen must preserve continuous insulin effect where required. Medication access, understanding, injection technique, glucose monitoring and follow-up become part of recurrence prevention.
15. Evidence, Uncertainty and Correction
The 2024 consensus was produced jointly by the ADA, EASD, JBDS, AACE and Diabetes Technology Society after systematic review of evidence since the previous consensus. Diagnostic and resolution criteria have changed over time, so eduKateAI should version this knowledge rather than treating old thresholds as permanent.
The correction loop is initial DKA/HHS classification → treatment → metabolic receipt → compare with expected trajectory → investigate persistent acidosis/hyperosmolality or alternative cause → update treatment → identify precipitant → prevent recurrence.
16. RFE: Did Metabolic Correction Return the Person Safely to Sustainable Diabetes Care?
The Medicine RFE asks whether timely, evidence-grounded and ethically authorised help reaches the human and improves outcomes without preventable harm. In DKA/HHS, success means restoring perfusion and metabolism safely, preventing dangerous electrolyte or osmotic shifts, identifying the precipitant, ensuring a workable insulin/diabetes plan and reducing the chance that the same crisis brings the person back to hospital.
eduKateAI DKA/HHS Tube Card
- CRISIS: DKA, HHS or mixed?
- GLUCOSE: level and trajectory?
- KETONES: beta-hydroxybutyrate/ketone state?
- ACID-BASE: pH/bicarbonate and trajectory?
- OSMOLALITY: effective/total osmolar state where relevant?
- VOLUME: dehydration, blood pressure, renal and cardiac constraints?
- POTASSIUM: current level and replacement need?
- INSULIN: route and response?
- PRECIPITANT: infection, missed insulin, new diabetes, cardiovascular event, medication or other?
- RESOLUTION: crisis-specific criteria met?
- TRANSITION: subcutaneous insulin/diabetes plan and monitoring?
- RETURN: education, access, sick-day plan and recurrence prevention?
Canonical External Source
2024 International Consensus Report — Hyperglycemic Crises in Adults With Diabetes
Educational boundary: DKA and HHS are medical emergencies. This page explains information architecture and does not diagnose a personal crisis, determine fluid or insulin doses, manage potassium, or replace urgent emergency and endocrine care.
